Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportDosimetry & Image Analysis

Evaluation of therapeutic alpha emitters for their potential to be used in FAPI compounds

Ashok Tiwari, Stephen Graves, Michael Merrick and John Sunderland
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2815;
Ashok Tiwari
1University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Graves
2University of Iowa Hospitals and Clinics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Merrick
1University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Sunderland
1University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2815

Introduction: There has been a significant interest in Fibroblast Activation Protein (FAP), which is highly expressed in cancer-associated fibroblasts (CAFs) of the tumor stroma. Recent studies have demonstrated that CAFs have emerged as important regulators of the anti-tumor immune response. Literature suggests that these cells are present in high density at the invasive front of the tumor stroma and have lower expression in the tumor center. The possibility of radiotherapeutic FAP-targeting compounds is being actively investigated. The unique situation where FAP radiotherapeutics target not cancer cells themselves, but CAFs distributed in and around the macroscopic tumor mass, it begs the question as to whether relatively short-range alpha-emitting radioisotopes are an appropriate therapeutic tool. Micro-dosimetric Monte Carlo (MC) simulations were performed to understand the potential of therapeutic effect of α-emitting radionuclides labeled to FAP-targeted compounds using several simplified CAF/tumor geometries.

Methods: We modeled a simple tumor microenvironment of the cubical volume of various sizes 50, 100, 200, 500, and 1000 µm. Three simple source configurations were modeled. α-emitting radionuclides were placed (a) at the edges of the cubical volume, (b) at the edges and placed at the center of the cubical volume, and (c) at the edges of the 3D volume and nine sources were placed in the cubical volume. All volumes were discretized such that each voxel represent a cell of a diameter of 10 µm. First, dose point kernels (DPKs) of therapeutic α-emitting radionuclides such as 227Th, 225Ac, 224Ra, 223Ra, 212Pb, 211At, 213Bi, and 212Bi were simulated in a water phantom. GATE MC simulations were performed by assuming an isotropic point source of radiation at the center of homogeneous water phantom. The particle energy losses were tallied when the complete decay spectra of radionuclide occur, including its descendants. Fifty million decays were simulated to provide sufficient statistical precision in simulated kernels. Second, the DPKs were convolved with the discretized cubical volumes to obtain the absorbed dose distribution. All voxels in the cubical volumes were assessed in MATLAB to create voxelized/per cell dose histograms.

Results: The voxels in the smaller cubical volume geometries (50 and 100 µm) were all irradiated primarily by α-particles from all eight α-emitting radionuclides decay and received a minimal absorbed dose from the daughter β-decay. When simulated CAF sources were more than 200 µm apart, a substantial portion of voxels received minimal and likely non-therapeutic doses, suggesting that a minimal density of CAFs of FAP targets will be necessary for effective α-radiotherapeutics.

Conclusions: We report the assessment of therapeutic α-emitters for their potential to be used in FAP targeting compounds for the treatment of metastatic tumors. MC simulations suggest that α-emitting radionuclides may be useful, but further studies are needed to more accurately simulate the complex distributions of sources in tumor microenvironments based upon actual microscopic distributions of CAFs in various tumor situations. Micro-dosimetric comparison of the dose profiles of the therapeutic radionuclides can be made using the kernels generated in this work.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of therapeutic alpha emitters for their potential to be used in FAPI compounds
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of therapeutic alpha emitters for their potential to be used in FAPI compounds
Ashok Tiwari, Stephen Graves, Michael Merrick, John Sunderland
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2815;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of therapeutic alpha emitters for their potential to be used in FAPI compounds
Ashok Tiwari, Stephen Graves, Michael Merrick, John Sunderland
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2815;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Development of a non-uniform rational B-Spline (NURBS) phantom for preclinical incorporation dosimetry with pigs
  • Preliminary Investigation of Using TOPAS-nBio to Simulate DNA Double-Strand Breaks from Volumetric Radioisotope Sources
  • Non-linearities in the Transition from Imaging Radiotracers to Therapeutic Radiopharmaceuticals
Show more Dosimetry & Image Analysis

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire